ZA9511033B - Gelling agent for polyethylene glycol - Google Patents

Gelling agent for polyethylene glycol

Info

Publication number
ZA9511033B
ZA9511033B ZA9511033A ZA9511033A ZA9511033B ZA 9511033 B ZA9511033 B ZA 9511033B ZA 9511033 A ZA9511033 A ZA 9511033A ZA 9511033 A ZA9511033 A ZA 9511033A ZA 9511033 B ZA9511033 B ZA 9511033B
Authority
ZA
South Africa
Prior art keywords
polyethylene glycol
gelling agent
gelling
agent
glycol
Prior art date
Application number
ZA9511033A
Other languages
English (en)
Inventor
Sharon L Cody
Michael R Hoy
Eric J Walter
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of ZA9511033B publication Critical patent/ZA9511033B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Colloid Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9511033A 1994-12-29 1995-12-28 Gelling agent for polyethylene glycol ZA9511033B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/366,271 US5660859A (en) 1994-12-29 1994-12-29 Gelling agent for polyethylene glycol

Publications (1)

Publication Number Publication Date
ZA9511033B true ZA9511033B (en) 1997-06-30

Family

ID=23442357

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9511033A ZA9511033B (en) 1994-12-29 1995-12-28 Gelling agent for polyethylene glycol

Country Status (9)

Country Link
US (2) US5660859A (fr)
EP (1) EP0719548B1 (fr)
JP (1) JPH08253412A (fr)
AU (1) AU692959B2 (fr)
DE (1) DE69509055T2 (fr)
DK (1) DK0719548T3 (fr)
ES (1) ES2131776T3 (fr)
NZ (1) NZ280609A (fr)
ZA (1) ZA9511033B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660859A (en) * 1994-12-29 1997-08-26 Mcneil-Ppc, Inc. Gelling agent for polyethylene glycol
KR20010005831A (ko) 1997-03-31 2001-01-15 이시하라 소이치 멜라닌형성 억제제, 피부 화장품 조성물 및 목욕용제
US6391282B1 (en) * 1997-11-10 2002-05-21 Flemington Pharmaceutical Corp. Antihistamine sprays and ointments for relief of delayed contact dermatitis
JP2002502908A (ja) 1998-02-06 2002-01-29 ユニオン・カーバイド・ケミカルズ・アンド・プラスティックス・テクノロジー・コーポレイション アルキレンオキシドポリマー組成物
US6432449B1 (en) * 1998-05-18 2002-08-13 Amgen Inc. Biodegradable sustained-release alginate gels
AU2003200609B2 (en) * 1998-05-18 2006-02-23 Amgen Inc. Biodegradable sustained-release alginate gels
US6251426B1 (en) 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
WO2002036077A2 (fr) * 2000-11-06 2002-05-10 Andrx Pharmaceuticals, Inc. Preparation decongestionnante et antihistaminique a prise quotidienne unique
US20030060422A1 (en) 2001-08-31 2003-03-27 Balaji Venkataraman Tannate compositions and methods of treatment
US7402323B2 (en) * 2002-08-21 2008-07-22 Akpharma, Inc. Compositions and methods for treating skin conditions
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
WO2008073614A2 (fr) * 2006-11-02 2008-06-19 Akpharma Inc. Composition et methode permettant d'ameliorer la croissance, la proliferation et la reparation de cellules cutanees
US20100255070A1 (en) * 2007-05-22 2010-10-07 Prelief Inc. Compositions and methods for preventing, minimizing and healing skin irritation and trauma
EP3064064A1 (fr) * 2009-09-30 2016-09-07 Acura Pharmaceuticals, Inc. Procédés et compositions de dissuasion d'abus
CN107595793B (zh) 2012-11-30 2020-11-13 阿库拉制药公司 活性药物成分的自调节释放
CA2919892C (fr) 2013-08-12 2019-06-18 Pharmaceutical Manufacturing Research Services, Inc. Comprime extrude anti-abus a liberation immediate
WO2015095391A1 (fr) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Comprimé extrudé anti-abus à libération prolongée
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
CA2943728C (fr) 2014-03-26 2020-03-24 Sun Pharma Advanced Research Company Ltd. Forme galenique solide de matrice biphasique a liberation immediate et dissuasive d'abus
EP3169315B1 (fr) 2014-07-17 2020-06-24 Pharmaceutical Manufacturing Research Services, Inc. Forme posologique remplie de liquide anti-abus à libération immédiate
WO2016064873A1 (fr) 2014-10-20 2016-04-28 Pharmaceutical Manufacturing Research Services, Inc. Forme galénique anti-abus de remplissage de liquide à libération prolongée
WO2017040607A1 (fr) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Procédés et compositions pour la libération auto-régulée d'un ingrédient pharmaceutique actif
CN109276549B (zh) * 2018-11-21 2020-07-21 海南赛立克药业有限公司 醋酸钙片及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1970396A (en) * 1931-10-12 1934-08-14 Robert P Scherer Method of and machine for making capsules
US2288327A (en) * 1935-10-08 1942-06-30 Robert P Scherer Apparatus for forming and filling capsules
US2318718A (en) * 1939-12-05 1943-05-11 Robert P Scherer Method and apparatus of fabricating filled capsules
US3851051A (en) * 1970-07-17 1974-11-26 Scherer R Corp Soft gelatin capsule containing high water content fill
US3996351A (en) * 1974-02-13 1976-12-07 Klaus Bauer Process for orally increasing the blood calcium level of animals
US4028024A (en) * 1974-10-31 1977-06-07 Moreland Stephen T Manufacture of filled capsules or the like
US4428927A (en) * 1981-05-11 1984-01-31 R. P. Scherer Corporation Masticatory soft elastic gelatin capsules and method for the manufacture thereof
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
US4467921A (en) * 1983-04-08 1984-08-28 Colgate-Palmolive Company Visually clear dentifrice
US4609403A (en) * 1984-03-12 1986-09-02 Warner-Lambert Company Foam soft gelatin capsules and their method of manufacture
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US4708412A (en) * 1986-05-20 1987-11-24 Amp Incorporated Electrical connector having low inductance shield
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
JP2562624B2 (ja) * 1986-11-07 1996-12-11 昭和電工株式会社 水溶性マイクロカプセルおよび液体洗剤組成物
US4844906A (en) * 1987-03-25 1989-07-04 Kv Pharmaceutical Company Tamper evident pharmaceutical capsule
US4883660A (en) * 1988-10-17 1989-11-28 Thames Pharmacal Co., Inc. Gel bases for pharmaceutical compositions
US4936074A (en) * 1988-11-17 1990-06-26 D. M. Graham Laboratories, Inc. Process for preparing solid encapsulated medicament
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5146730A (en) * 1989-09-20 1992-09-15 Banner Gelatin Products Corp. Film-enrobed unitary-core medicament and the like
DD298351A5 (de) * 1989-11-06 1992-02-20 Jenapharm Gmbh,De Verfahren zur herstellung einer carrierabhaengigen arzneiform
GB8926612D0 (en) * 1989-11-24 1990-01-17 Erba Farmitalia Pharmaceutical compositions
GB2253213B (en) * 1991-01-24 1995-03-08 Tokyo Yogyo Kk Injection part for die-casting machines
DE4201178C2 (de) * 1992-01-17 1995-12-07 Alfatec Pharma Gmbh Verfahren zur Herstellung von Weichgelatinekapseln nach einem Tropfverfahren
US5505961A (en) * 1993-08-05 1996-04-09 R. P. Scherer Corporation Gelatin capsules containing a highly concentrated acetaminophen solution
US5660859A (en) * 1994-12-29 1997-08-26 Mcneil-Ppc, Inc. Gelling agent for polyethylene glycol

Also Published As

Publication number Publication date
US5660859A (en) 1997-08-26
AU692959B2 (en) 1998-06-18
AU4050295A (en) 1996-07-04
DE69509055D1 (de) 1999-05-20
JPH08253412A (ja) 1996-10-01
ES2131776T3 (es) 1999-08-01
EP0719548B1 (fr) 1999-04-14
DE69509055T2 (de) 1999-08-19
US5840337A (en) 1998-11-24
DK0719548T3 (da) 1999-06-23
EP0719548A1 (fr) 1996-07-03
NZ280609A (en) 1997-11-24

Similar Documents

Publication Publication Date Title
ZA9511033B (en) Gelling agent for polyethylene glycol
PL305701A1 (en) Pharmaceutical agent
IL116318A (en) Polyethylene composition
EP0943327A4 (fr) Compositions medicinales
EP0803255A4 (fr) Composition medicinale
EP0688555A3 (fr) Agent pour la croissance des cheveux
GB2318814B (en) Foamable gel composition
HU9603591D0 (en) Co-dependent guanilyl-cyclase modificating agent
EP0843964A4 (fr) Agent hydratant granulaire
GB2319937B (en) Multi-integrated agent system
CZ48495A3 (en) Interchange station
GB9715561D0 (en) Non-foamable gel shaving composition
ZA952017B (en) Veterinary formulation
GB2328783B (en) Gel type decontamination agent
EP0935965A4 (fr) Agent anti-pylori
HUT71045A (en) Gazoline-filling station
GB9407658D0 (en) Veterinary formulation
EP0760748A4 (fr) Dispositif de rangement
GB9404989D0 (en) Lipomimetric formulation
GB9407726D0 (en) Pharmaceutical agent
HUP9903411A3 (en) Wood-protecting agent
GB9418663D0 (en) Storage apparatus
GB9410025D0 (en) Storage apparatus
GB9621560D0 (en) Sealing agent
GB9323041D0 (en) Gel forming agent